Momelotinib
CAS 1056634-68-4Small Molecule
Overview
Momelotinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1078178).
Patent & exclusivity (US)
Per the FDA Orange Book (3 approved US products), the latest listed US patent on Momelotinib expires 2 Dec 2040 and exclusivity 15 Sept 2030. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide
- Canonical SMILES
- C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N
- InChIKey
- ZVHNDZWQTBEVRY-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Momelotinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.